nodes	percent_of_prediction	percent_of_DWPC	metapath
Nortriptyline—CHRM3—ureter—cervical cancer	0.143	0.22	CbGeAlD
Nortriptyline—CHRM3—exocrine gland—cervical cancer	0.0282	0.0434	CbGeAlD
Nortriptyline—CHRM5—epithelium—cervical cancer	0.0219	0.0338	CbGeAlD
Nortriptyline—ADRA1D—epithelium—cervical cancer	0.0196	0.0302	CbGeAlD
Nortriptyline—ADRA1B—renal system—cervical cancer	0.0186	0.0286	CbGeAlD
Nortriptyline—ADRA1D—female reproductive system—cervical cancer	0.0146	0.0224	CbGeAlD
Nortriptyline—ORM1—endometrium—cervical cancer	0.0145	0.0223	CbGeAlD
Nortriptyline—ORM1—female reproductive system—cervical cancer	0.012	0.0185	CbGeAlD
Nortriptyline—SLC6A2—decidua—cervical cancer	0.0114	0.0176	CbGeAlD
Nortriptyline—CHRM3—renal system—cervical cancer	0.0114	0.0175	CbGeAlD
Nortriptyline—HTR1A—renal system—cervical cancer	0.0113	0.0174	CbGeAlD
Nortriptyline—ADRA1A—epithelium—cervical cancer	0.0113	0.0173	CbGeAlD
Nortriptyline—HTR2C—female reproductive system—cervical cancer	0.0108	0.0166	CbGeAlD
Nortriptyline—ADRA1A—renal system—cervical cancer	0.0104	0.0161	CbGeAlD
Nortriptyline—SLC6A4—female reproductive system—cervical cancer	0.0102	0.0157	CbGeAlD
Nortriptyline—CHRM1—female reproductive system—cervical cancer	0.0102	0.0157	CbGeAlD
Nortriptyline—CHRM3—female reproductive system—cervical cancer	0.00911	0.014	CbGeAlD
Nortriptyline—SLC6A2—female reproductive system—cervical cancer	0.009	0.0139	CbGeAlD
Nortriptyline—CYP3A5—uterine cervix—cervical cancer	0.0089	0.0137	CbGeAlD
Nortriptyline—HRH1—epithelium—cervical cancer	0.00872	0.0134	CbGeAlD
Nortriptyline—HRH1—uterine cervix—cervical cancer	0.00864	0.0133	CbGeAlD
Nortriptyline—CYP1A2—renal system—cervical cancer	0.00864	0.0133	CbGeAlD
Nortriptyline—CYP3A5—renal system—cervical cancer	0.00833	0.0128	CbGeAlD
Nortriptyline—CHRM3—female gonad—cervical cancer	0.00829	0.0128	CbGeAlD
Nortriptyline—HRH1—decidua—cervical cancer	0.00823	0.0127	CbGeAlD
Nortriptyline—PTGS1—epithelium—cervical cancer	0.00807	0.0124	CbGeAlD
Nortriptyline—PTGS1—uterine cervix—cervical cancer	0.008	0.0123	CbGeAlD
Nortriptyline—HRH1—endometrium—cervical cancer	0.00782	0.012	CbGeAlD
Nortriptyline—CYP2E1—renal system—cervical cancer	0.00777	0.012	CbGeAlD
Nortriptyline—CYP2C19—vagina—cervical cancer	0.00766	0.0118	CbGeAlD
Nortriptyline—HRH1—mammalian vulva—cervical cancer	0.00756	0.0116	CbGeAlD
Nortriptyline—PTGS1—renal system—cervical cancer	0.00748	0.0115	CbGeAlD
Nortriptyline—HTR2A—epithelium—cervical cancer	0.00728	0.0112	CbGeAlD
Nortriptyline—PTGS1—endometrium—cervical cancer	0.00724	0.0111	CbGeAlD
Nortriptyline—ORM1—lymph node—cervical cancer	0.00702	0.0108	CbGeAlD
Nortriptyline—PTGS1—mammalian vulva—cervical cancer	0.007	0.0108	CbGeAlD
Nortriptyline—HTR2A—renal system—cervical cancer	0.00675	0.0104	CbGeAlD
Nortriptyline—PTGS1—uterus—cervical cancer	0.00667	0.0103	CbGeAlD
Nortriptyline—CYP2C9—female reproductive system—cervical cancer	0.00657	0.0101	CbGeAlD
Nortriptyline—HRH1—female reproductive system—cervical cancer	0.00648	0.00997	CbGeAlD
Nortriptyline—CYP3A4—renal system—cervical cancer	0.00625	0.00963	CbGeAlD
Nortriptyline—CYP2E1—female reproductive system—cervical cancer	0.00622	0.00958	CbGeAlD
Nortriptyline—ALB—lymph node—cervical cancer	0.00615	0.00947	CbGeAlD
Nortriptyline—CYP2D6—renal system—cervical cancer	0.00615	0.00947	CbGeAlD
Nortriptyline—CYP3A5—female gonad—cervical cancer	0.00607	0.00935	CbGeAlD
Nortriptyline—CYP3A5—vagina—cervical cancer	0.00603	0.00929	CbGeAlD
Nortriptyline—PTGS1—female reproductive system—cervical cancer	0.00599	0.00923	CbGeAlD
Nortriptyline—HRH1—female gonad—cervical cancer	0.00589	0.00907	CbGeAlD
Nortriptyline—HRH1—vagina—cervical cancer	0.00586	0.00902	CbGeAlD
Nortriptyline—PTGS1—female gonad—cervical cancer	0.00545	0.0084	CbGeAlD
Nortriptyline—PTGS1—vagina—cervical cancer	0.00542	0.00835	CbGeAlD
Nortriptyline—HTR2A—female reproductive system—cervical cancer	0.00541	0.00833	CbGeAlD
Nortriptyline—SLC6A2—lymph node—cervical cancer	0.00526	0.0081	CbGeAlD
Nortriptyline—CYP3A4—female reproductive system—cervical cancer	0.00501	0.00771	CbGeAlD
Nortriptyline—CYP2D6—female reproductive system—cervical cancer	0.00493	0.00759	CbGeAlD
Nortriptyline—HTR2A—vagina—cervical cancer	0.00489	0.00753	CbGeAlD
Nortriptyline—CYP2D6—female gonad—cervical cancer	0.00448	0.0069	CbGeAlD
Nortriptyline—HRH1—lymph node—cervical cancer	0.00379	0.00583	CbGeAlD
Nortriptyline—PTGS1—lymph node—cervical cancer	0.00351	0.0054	CbGeAlD
Nortriptyline—ADRA1D—Signaling Pathways—WNT2—cervical cancer	0.000335	0.000956	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—WNT5A—cervical cancer	0.000329	0.000938	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TAAR6—cervical cancer	0.000328	0.000937	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—AKAP13—cervical cancer	0.000327	0.000932	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—WNT5A—cervical cancer	0.000324	0.000923	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TAAR6—cervical cancer	0.000323	0.000922	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—WNT5A—cervical cancer	0.000323	0.000921	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TAAR6—cervical cancer	0.000322	0.00092	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—WNT5A—cervical cancer	0.000322	0.000918	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TAAR6—cervical cancer	0.000321	0.000917	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—WNT5A—cervical cancer	0.000321	0.000915	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TAAR6—cervical cancer	0.00032	0.000914	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—CA9—cervical cancer	0.000318	0.000909	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—WNT5A—cervical cancer	0.000318	0.000906	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TAAR6—cervical cancer	0.000317	0.000905	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—WNT5A—cervical cancer	0.000317	0.000904	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TAAR6—cervical cancer	0.000316	0.000903	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—AKAP13—cervical cancer	0.000313	0.000892	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—WNT5A—cervical cancer	0.000299	0.000853	CbGpPWpGaD
Nortriptyline—HTR2C—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000294	0.00084	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—AKAP13—cervical cancer	0.000294	0.000839	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—WNT2—cervical cancer	0.000292	0.000833	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—WNT2—cervical cancer	0.00029	0.000829	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—CA9—cervical cancer	0.000282	0.000806	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—WNT5A—cervical cancer	0.000282	0.000804	CbGpPWpGaD
Nortriptyline—ADRA1B—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000282	0.000804	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—WNT2—cervical cancer	0.000278	0.000793	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—WNT5A—cervical cancer	0.00027	0.00077	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—WNT2—cervical cancer	0.000256	0.000731	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—AKAP13—cervical cancer	0.000256	0.000731	CbGpPWpGaD
Nortriptyline—HTR2A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000256	0.000729	CbGpPWpGaD
Nortriptyline—HRH1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000255	0.000728	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—AKAP13—cervical cancer	0.000255	0.000728	CbGpPWpGaD
Nortriptyline—CHRM1—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000254	0.000726	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—WNT5A—cervical cancer	0.000254	0.000724	CbGpPWpGaD
Nortriptyline—CHRM3—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.000253	0.000723	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—WNT2—cervical cancer	0.000252	0.00072	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—WNT2—cervical cancer	0.000252	0.000718	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—WNT2—cervical cancer	0.000251	0.000716	CbGpPWpGaD
Nortriptyline—ADRA1A—Gastrin-CREB signalling pathway via PKC and MAPK—EGFR—cervical cancer	0.00025	0.000714	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—WNT2—cervical cancer	0.00025	0.000713	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—WNT2—cervical cancer	0.000248	0.000707	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—WNT2—cervical cancer	0.000247	0.000705	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—AKAP13—cervical cancer	0.000244	0.000696	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—CA9—cervical cancer	0.000238	0.000679	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—CA9—cervical cancer	0.000237	0.000678	CbGpPWpGaD
Nortriptyline—DRD2—Circadian rythm related genes—TP53—cervical cancer	0.00023	0.000657	CbGpPWpGaD
Nortriptyline—CHRM1—Circadian rythm related genes—TP53—cervical cancer	0.000225	0.000643	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—AKAP13—cervical cancer	0.000225	0.000642	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—AKAP13—cervical cancer	0.000221	0.000632	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—WNT5A—cervical cancer	0.000221	0.000631	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—AKAP13—cervical cancer	0.000221	0.00063	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—AKAP13—cervical cancer	0.00022	0.000628	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—WNT5A—cervical cancer	0.00022	0.000628	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—AKAP13—cervical cancer	0.00022	0.000626	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—AKAP13—cervical cancer	0.000217	0.00062	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—AKAP13—cervical cancer	0.000217	0.000619	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—WNT5A—cervical cancer	0.000211	0.000601	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—NOTCH2—cervical cancer	0.00021	0.000599	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—CA9—cervical cancer	0.000205	0.000584	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—NOTCH2—cervical cancer	0.000198	0.000565	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—WNT5A—cervical cancer	0.000194	0.000554	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—WNT5A—cervical cancer	0.000191	0.000545	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—WNT5A—cervical cancer	0.000191	0.000544	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—WNT5A—cervical cancer	0.00019	0.000542	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—WNT5A—cervical cancer	0.00019	0.000541	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—NOTCH2—cervical cancer	0.00019	0.000541	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—WNT5A—cervical cancer	0.000188	0.000535	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—WNT5A—cervical cancer	0.000187	0.000534	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—CA9—cervical cancer	0.000184	0.000524	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—NOTCH2—cervical cancer	0.000178	0.000508	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—HES1—cervical cancer	0.000172	0.000491	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—CA9—cervical cancer	0.000169	0.000482	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—CA9—cervical cancer	0.000167	0.000478	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—HES1—cervical cancer	0.000162	0.000463	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—HES1—cervical cancer	0.000155	0.000443	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NOTCH2—cervical cancer	0.000155	0.000443	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NOTCH2—cervical cancer	0.000154	0.000441	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TERT—cervical cancer	0.000151	0.00043	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NOTCH2—cervical cancer	0.000148	0.000422	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—HES1—cervical cancer	0.000146	0.000417	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—CA9—cervical cancer	0.000143	0.000408	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TERT—cervical cancer	0.000142	0.000406	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—FGFR3—cervical cancer	0.000138	0.000395	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NOTCH2—cervical cancer	0.000136	0.000389	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TERT—cervical cancer	0.000136	0.000388	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NOTCH2—cervical cancer	0.000134	0.000383	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NOTCH2—cervical cancer	0.000134	0.000382	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NOTCH2—cervical cancer	0.000133	0.000381	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NOTCH2—cervical cancer	0.000133	0.000379	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NOTCH2—cervical cancer	0.000132	0.000376	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NOTCH2—cervical cancer	0.000131	0.000375	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—FGFR3—cervical cancer	0.00013	0.000372	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—NOTCH1—cervical cancer	0.00013	0.00037	CbGpPWpGaD
Nortriptyline—PTGS1—Metabolism—MTHFR—cervical cancer	0.000129	0.000369	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TERT—cervical cancer	0.000128	0.000365	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—HES1—cervical cancer	0.000127	0.000363	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—HES1—cervical cancer	0.000127	0.000361	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—FGFR3—cervical cancer	0.000125	0.000356	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—NOTCH1—cervical cancer	0.000122	0.000349	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—HES1—cervical cancer	0.000121	0.000346	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—FGFR3—cervical cancer	0.000117	0.000335	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—NOTCH1—cervical cancer	0.000117	0.000335	CbGpPWpGaD
Nortriptyline—HTR6—Signaling by GPCR—EGFR—cervical cancer	0.000116	0.00033	CbGpPWpGaD
Nortriptyline—CHRM3—Metabolism—MTHFR—cervical cancer	0.000115	0.000327	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—HES1—cervical cancer	0.000112	0.000319	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TERT—cervical cancer	0.000112	0.000318	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TERT—cervical cancer	0.000111	0.000317	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—CA9—cervical cancer	0.00011	0.000315	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—NOTCH1—cervical cancer	0.00011	0.000315	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—HES1—cervical cancer	0.00011	0.000314	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—HES1—cervical cancer	0.00011	0.000313	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—HES1—cervical cancer	0.000109	0.000312	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling by GPCR—EGFR—cervical cancer	0.000109	0.000311	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—HES1—cervical cancer	0.000109	0.000311	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—HES1—cervical cancer	0.000108	0.000308	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—HES1—cervical cancer	0.000108	0.000307	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TERT—cervical cancer	0.000106	0.000303	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling by GPCR—EGFR—cervical cancer	0.000105	0.000298	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—FGFR3—cervical cancer	0.000102	0.000292	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—FGFR3—cervical cancer	0.000102	0.000291	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling by GPCR—EGFR—cervical cancer	9.83e-05	0.00028	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TERT—cervical cancer	9.8e-05	0.000279	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—FGFR3—cervical cancer	9.75e-05	0.000278	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—MTOR—cervical cancer	9.73e-05	0.000278	CbGpPWpGaD
Nortriptyline—CYP2E1—Metabolism—MTHFR—cervical cancer	9.66e-05	0.000276	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TERT—cervical cancer	9.64e-05	0.000275	CbGpPWpGaD
Nortriptyline—CYP3A5—Metabolism—MTHFR—cervical cancer	9.64e-05	0.000275	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TERT—cervical cancer	9.62e-05	0.000274	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—NOTCH1—cervical cancer	9.61e-05	0.000274	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TERT—cervical cancer	9.59e-05	0.000274	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—NOTCH1—cervical cancer	9.56e-05	0.000273	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TERT—cervical cancer	9.56e-05	0.000273	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TERT—cervical cancer	9.46e-05	0.00027	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TERT—cervical cancer	9.44e-05	0.000269	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—MTOR—cervical cancer	9.18e-05	0.000262	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—NOTCH1—cervical cancer	9.15e-05	0.000261	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—FGFR3—cervical cancer	8.99e-05	0.000256	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CASP3—cervical cancer	8.95e-05	0.000255	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—FGFR3—cervical cancer	8.85e-05	0.000252	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—FGFR3—cervical cancer	8.83e-05	0.000252	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—FGFR3—cervical cancer	8.8e-05	0.000251	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—MTOR—cervical cancer	8.79e-05	0.000251	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—FGFR3—cervical cancer	8.77e-05	0.00025	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—FGFR3—cervical cancer	8.68e-05	0.000248	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—FGFR3—cervical cancer	8.66e-05	0.000247	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—CTNNB1—cervical cancer	8.63e-05	0.000246	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling by GPCR—EGFR—cervical cancer	8.56e-05	0.000244	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling by GPCR—EGFR—cervical cancer	8.52e-05	0.000243	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CASP3—cervical cancer	8.44e-05	0.000241	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—NOTCH1—cervical cancer	8.44e-05	0.000241	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—NOTCH1—cervical cancer	8.3e-05	0.000237	CbGpPWpGaD
Nortriptyline—ALB—Metabolism—MTHFR—cervical cancer	8.3e-05	0.000237	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—NOTCH1—cervical cancer	8.29e-05	0.000236	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—MTOR—cervical cancer	8.26e-05	0.000236	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—NOTCH1—cervical cancer	8.26e-05	0.000236	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—NOTCH1—cervical cancer	8.23e-05	0.000235	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling by GPCR—EGFR—cervical cancer	8.16e-05	0.000233	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—NOTCH1—cervical cancer	8.15e-05	0.000233	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—CTNNB1—cervical cancer	8.14e-05	0.000232	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—NOTCH1—cervical cancer	8.13e-05	0.000232	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CASP3—cervical cancer	8.08e-05	0.000231	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—CTNNB1—cervical cancer	7.79e-05	0.000222	CbGpPWpGaD
Nortriptyline—ALB—Hemostasis—TP53—cervical cancer	7.77e-05	0.000222	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CASP3—cervical cancer	7.6e-05	0.000217	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—STAT3—cervical cancer	7.52e-05	0.000215	CbGpPWpGaD
Nortriptyline—DRD2—Signaling by GPCR—EGFR—cervical cancer	7.52e-05	0.000215	CbGpPWpGaD
Nortriptyline—CYP2C19—Metabolism—MTHFR—cervical cancer	7.45e-05	0.000213	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling by GPCR—EGFR—cervical cancer	7.4e-05	0.000211	CbGpPWpGaD
Nortriptyline—HRH1—Signaling by GPCR—EGFR—cervical cancer	7.38e-05	0.000211	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling by GPCR—EGFR—cervical cancer	7.36e-05	0.00021	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling by GPCR—EGFR—cervical cancer	7.34e-05	0.000209	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—CTNNB1—cervical cancer	7.33e-05	0.000209	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling by GPCR—EGFR—cervical cancer	7.26e-05	0.000207	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling by GPCR—EGFR—cervical cancer	7.24e-05	0.000207	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—MTOR—cervical cancer	7.2e-05	0.000205	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—MTOR—cervical cancer	7.17e-05	0.000204	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—STAT3—cervical cancer	7.09e-05	0.000202	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—MTOR—cervical cancer	6.86e-05	0.000196	CbGpPWpGaD
Nortriptyline—CYP2D6—Metabolism—MTHFR—cervical cancer	6.85e-05	0.000196	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—EGFR—cervical cancer	6.83e-05	0.000195	CbGpPWpGaD
Nortriptyline—CYP2C9—Metabolism—MTHFR—cervical cancer	6.79e-05	0.000194	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—STAT3—cervical cancer	6.79e-05	0.000194	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CASP3—cervical cancer	6.62e-05	0.000189	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CASP3—cervical cancer	6.59e-05	0.000188	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—EGFR—cervical cancer	6.45e-05	0.000184	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—STAT3—cervical cancer	6.39e-05	0.000182	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—CTNNB1—cervical cancer	6.39e-05	0.000182	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—CTNNB1—cervical cancer	6.35e-05	0.000181	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—MTOR—cervical cancer	6.32e-05	0.00018	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CASP3—cervical cancer	6.31e-05	0.00018	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—MTOR—cervical cancer	6.22e-05	0.000178	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—MTOR—cervical cancer	6.21e-05	0.000177	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—MTOR—cervical cancer	6.19e-05	0.000177	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—EGFR—cervical cancer	6.17e-05	0.000176	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—MTOR—cervical cancer	6.17e-05	0.000176	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—MTOR—cervical cancer	6.11e-05	0.000174	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—MTOR—cervical cancer	6.09e-05	0.000174	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—CTNNB1—cervical cancer	6.08e-05	0.000174	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CASP3—cervical cancer	5.82e-05	0.000166	CbGpPWpGaD
Nortriptyline—CYP1A2—Metabolism—MTHFR—cervical cancer	5.81e-05	0.000166	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—EGFR—cervical cancer	5.8e-05	0.000166	CbGpPWpGaD
Nortriptyline—HTR6—Signaling Pathways—TP53—cervical cancer	5.74e-05	0.000164	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CASP3—cervical cancer	5.72e-05	0.000163	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CASP3—cervical cancer	5.71e-05	0.000163	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CASP3—cervical cancer	5.69e-05	0.000162	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CASP3—cervical cancer	5.67e-05	0.000162	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CASP3—cervical cancer	5.62e-05	0.00016	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—CTNNB1—cervical cancer	5.61e-05	0.00016	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CASP3—cervical cancer	5.6e-05	0.00016	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—STAT3—cervical cancer	5.57e-05	0.000159	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—STAT3—cervical cancer	5.54e-05	0.000158	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—CTNNB1—cervical cancer	5.52e-05	0.000157	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—CTNNB1—cervical cancer	5.5e-05	0.000157	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—CTNNB1—cervical cancer	5.49e-05	0.000157	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—CTNNB1—cervical cancer	5.47e-05	0.000156	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—CTNNB1—cervical cancer	5.42e-05	0.000155	CbGpPWpGaD
Nortriptyline—CHRM4—Signaling Pathways—TP53—cervical cancer	5.41e-05	0.000154	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—CTNNB1—cervical cancer	5.4e-05	0.000154	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—STAT3—cervical cancer	5.3e-05	0.000151	CbGpPWpGaD
Nortriptyline—CHRM5—Signaling Pathways—TP53—cervical cancer	5.18e-05	0.000148	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—EGFR—cervical cancer	5.06e-05	0.000144	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—EGFR—cervical cancer	5.03e-05	0.000144	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—STAT3—cervical cancer	4.89e-05	0.000139	CbGpPWpGaD
Nortriptyline—ADRA1D—Signaling Pathways—TP53—cervical cancer	4.87e-05	0.000139	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—EGFR—cervical cancer	4.82e-05	0.000137	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—STAT3—cervical cancer	4.81e-05	0.000137	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—STAT3—cervical cancer	4.8e-05	0.000137	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—STAT3—cervical cancer	4.78e-05	0.000136	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—STAT3—cervical cancer	4.77e-05	0.000136	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—STAT3—cervical cancer	4.72e-05	0.000135	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—STAT3—cervical cancer	4.71e-05	0.000134	CbGpPWpGaD
Nortriptyline—CYP3A4—Metabolism—MTHFR—cervical cancer	4.48e-05	0.000128	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—EGFR—cervical cancer	4.44e-05	0.000127	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—EGFR—cervical cancer	4.37e-05	0.000125	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—EGFR—cervical cancer	4.36e-05	0.000124	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—EGFR—cervical cancer	4.35e-05	0.000124	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—EGFR—cervical cancer	4.33e-05	0.000124	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—EGFR—cervical cancer	4.29e-05	0.000122	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—EGFR—cervical cancer	4.28e-05	0.000122	CbGpPWpGaD
Nortriptyline—HTR1A—Signaling Pathways—TP53—cervical cancer	4.25e-05	0.000121	CbGpPWpGaD
Nortriptyline—HTR2C—Signaling Pathways—TP53—cervical cancer	4.23e-05	0.000121	CbGpPWpGaD
Nortriptyline—ADRA1B—Signaling Pathways—TP53—cervical cancer	4.05e-05	0.000115	CbGpPWpGaD
Nortriptyline—DRD2—Signaling Pathways—TP53—cervical cancer	3.73e-05	0.000106	CbGpPWpGaD
Nortriptyline—HTR2A—Signaling Pathways—TP53—cervical cancer	3.67e-05	0.000105	CbGpPWpGaD
Nortriptyline—HRH1—Signaling Pathways—TP53—cervical cancer	3.66e-05	0.000104	CbGpPWpGaD
Nortriptyline—CHRM1—Signaling Pathways—TP53—cervical cancer	3.65e-05	0.000104	CbGpPWpGaD
Nortriptyline—CHRM3—Signaling Pathways—TP53—cervical cancer	3.64e-05	0.000104	CbGpPWpGaD
Nortriptyline—CHRM2—Signaling Pathways—TP53—cervical cancer	3.6e-05	0.000103	CbGpPWpGaD
Nortriptyline—ADRA1A—Signaling Pathways—TP53—cervical cancer	3.59e-05	0.000103	CbGpPWpGaD
